Q2 2026 13F · SEC CIK 1179475
Hussman Strategic Advisors, Inc.
Mutual fund managerFiled 2026-08-03 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $434.0M
- Reported positions
- 231
- Top holdings a year, 3 yrs
- +32.1%
- Assets under management
- $617.4M
Hussman Strategic Advisors, Inc. is a mutual fund manager that reported 231 positions worth $434.0M in its Q2 2026 13F, filed 2026-08-03. Its largest holdings were Pepsico Inc (PEP, 1.2%), Ubiquiti Inc (UI, 1.2%), Incyte Corp (INCY, 1.1%). A portfolio copying its top holdings returned 32.1% a year over the last 3 years, against 20.4% for the S&P 500.
Hussman Strategic Advisors, Inc. holdings largest 50 of 231 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
What Hussman Strategic Advisors, Inc. bought and sold in Q2 2026, against Q1 2026.
New positions
Q1 2026's filing was too long to tell new positions apart.
Added to
- UI Ubiquiti Inc+125.0% shares
- INCY Incyte Corp+33.3% shares
- NBIX Neurocrine Biosciences Inc+30.0% shares
- TR Tootsie Roll Inds Inc+29.4% shares
- ULTA Ulta Beauty Inc+14.3% shares
Reduced
- ETSY Etsy Inc-50.0% shares
- VSAT Viasat Inc-28.6% shares
- HCSG Healthcare Svcs Group Inc-25.0% shares
- UNFI United Nat Foods Inc-20.0% shares
- CPB The Campbells Company-20.0% shares
- PRLB Proto Labs Inc-20.0% shares
- HALO Halozyme Therapeutics Inc-20.0% shares
- AMRC Ameresco Inc-16.7% shares
Left the top 50
- CORT Corcept Therapeutics Inc Comwas 1.1%
- ANIP Ani Pharmaceuticals Incwas 0.9%
- CNXC Concentrix Corpwas 0.9%
- SEZL Sezzle Inc.was 0.9%
- PSIX Power Solutions Intl Incwas 0.8%
- ACAD Acadia Pharmaceuticals Incwas 0.8%
- QLYS Qualys Incwas 0.8%
- PGNY Progyny Incwas 0.8%
Share counts compared with the Q1 2026 13F; a split also changes share counts. The latest filing lists more than 50 positions, so a position that left the top 50 may still be held.
How the holdings did against the S&P 500.
- 1 year
- +55.4% /yr
- S&P 500 +20.1%
- 3 years
- +32.1% /yr
- S&P 500 +20.4%
- 5 years
- +21.9% /yr
- S&P 500 +11.6%
A portfolio of the filer's 20 largest 13F positions, weighted by value and rebuilt each quarter on the day the filing became public. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $434.0M | 231 |
| Q1 2026 | $462.5M | 268 |
| Q4 2025 | $413.7M | 252 |
| Q3 2025 | $461.8M | 270 |
| Q2 2025 | $437.6M | 210 |
| Q1 2025 | $412.6M | 232 |
| Q4 2024 | $338.5M | 234 |
| Q3 2024 | $407.1M | 216 |
| Q2 2024 | $363.0M | 232 |
| Q1 2024 | $430.0M | 216 |
| Q4 2023 | $439.9M | 222 |
| Q3 2023 | $523.9M | 296 |
Questions about Hussman Strategic Advisors, Inc.'s portfolio
What stocks does Hussman Strategic Advisors, Inc. own?
Hussman Strategic Advisors, Inc.'s latest 13F, for Q2 2026 and filed Aug 3, 2026, lists 231 positions worth $434.0M. The largest are Pepsico Inc (PEP) at 1.2%, Ubiquiti Inc (UI) at 1.2%, Incyte Corp (INCY) at 1.1%, Viasat Inc (VSAT) at 1.1% and Neurocrine Biosciences Inc (NBIX) at 1.1%.
What did Hussman Strategic Advisors, Inc. buy last quarter?
In Q2 2026, Hussman Strategic Advisors, Inc. added Ubiquiti Inc (UI) (+125.0% shares), Incyte Corp (INCY) (+33.3% shares) and Neurocrine Biosciences Inc (NBIX) (+30.0% shares), compared with its Q1 2026 filing.
What did Hussman Strategic Advisors, Inc. sell last quarter?
In Q2 2026, Hussman Strategic Advisors, Inc. cut from its top 50 Corcept Therapeutics Inc Com (CORT), cut from its top 50 Ani Pharmaceuticals Inc (ANIP), cut from its top 50 Concentrix Corp (CNXC), cut from its top 50 Sezzle Inc. (SEZL), cut from its top 50 Power Solutions Intl Inc (PSIX), Etsy Inc (ETSY) (-50.0% shares), Viasat Inc (VSAT) (-28.6% shares) and Healthcare Svcs Group Inc (HCSG) (-25.0% shares), compared with its Q1 2026 filing.
How has Hussman Strategic Advisors, Inc.'s portfolio performed?
A portfolio copying Hussman Strategic Advisors, Inc.'s 20 largest 13F holdings each quarter, from the day each filing was public, returned +32.1% a year over the last 3 years, against +20.4% for the S&P 500. Over 1 year: +55.4% against +20.1%. Over 5 years: +21.9% a year against +11.6%.
When is Hussman Strategic Advisors, Inc.'s next 13F filing due?
13F filings are due 45 days after each quarter ends. Hussman Strategic Advisors, Inc.'s filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.
How much money does Hussman Strategic Advisors, Inc. manage?
Hussman Strategic Advisors, Inc. reported $617.4M of regulatory assets under management on its latest SEC Form ADV. Its 13F, which covers only US-listed stocks and options, totals $434.0M.